- Home
- LEGT vs NPCE Comparison
LEGT vs NPCE Comparison
Compare LEGT & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGT
- NPCE
- Stock Information
- Founded
- LEGT 2023
- NPCE 1997
- Country
- LEGT United States
- NPCE United States
- Employees
- LEGT N/A
- NPCE N/A
- Industry
- LEGT
- NPCE Medical Specialities
- Sector
- LEGT
- NPCE Health Care
- Exchange
- LEGT Nasdaq
- NPCE Nasdaq
- Market Cap
- LEGT 277.1M
- NPCE 312.2M
- IPO Year
- LEGT 2024
- NPCE 2021
- Fundamental
- Price
- LEGT $10.74
- NPCE $8.98
- Analyst Decision
- LEGT
- NPCE Strong Buy
- Analyst Count
- LEGT 0
- NPCE 6
- Target Price
- LEGT N/A
- NPCE $16.33
- AVG Volume (30 Days)
- LEGT 10.9K
- NPCE 340.9K
- Earning Date
- LEGT 01-01-0001
- NPCE 08-12-2025
- Dividend Yield
- LEGT N/A
- NPCE N/A
- EPS Growth
- LEGT N/A
- NPCE N/A
- EPS
- LEGT 0.35
- NPCE N/A
- Revenue
- LEGT N/A
- NPCE $84,306,000.00
- Revenue This Year
- LEGT N/A
- NPCE $21.04
- Revenue Next Year
- LEGT N/A
- NPCE $10.73
- P/E Ratio
- LEGT $0.88
- NPCE N/A
- Revenue Growth
- LEGT N/A
- NPCE 22.05
- 52 Week Low
- LEGT $10.15
- NPCE $5.45
- 52 Week High
- LEGT $10.86
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- LEGT N/A
- NPCE 31.44
- Support Level
- LEGT N/A
- NPCE $9.00
- Resistance Level
- LEGT N/A
- NPCE $9.61
- Average True Range (ATR)
- LEGT 0.00
- NPCE 0.42
- MACD
- LEGT 0.00
- NPCE 0.05
- Stochastic Oscillator
- LEGT 0.00
- NPCE 10.61
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.